Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: comment

Conflict of interest

The authors declare no potential conflict of interest.

Ethical, Human and animal rights and Informed consent

The study complies with the principles outlined in the Declaration of Helsinki, and the study was approved by the Hacettepe University Non-Interventional Clinical Research Ethics Committee (assessment date: July 5, 2022, project number: GO 22/734, decision number: GO 2022/12–29).

Comments (0)

No login
gif